human | Q5 |
P496 | ORCID iD | 0000-0001-5463-1551 |
P1053 | ResearcherID | E-3319-2010 |
P69 | educated at | Yamagata University | Q1196888 |
P108 | employer | Tufts Medical Center | Q7851542 |
Harvard Medical School | Q49121 | ||
Massachusetts General Hospital | Q126412 | ||
P106 | occupation | researcher | Q1650915 |
Q36283354 | Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis |
Q33601965 | Constitutive WNT/beta-catenin signaling in murine Sertoli cells disrupts their differentiation and ability to support spermatogenesis |
Q30370194 | Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria. |
Q37616060 | Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. |
Q27335766 | Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN |
Q80507113 | Maternal and embryonic control of uterine sphingolipid-metabolizing enzymes during murine embryo implantation |
Q34390606 | Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1. |